Survey on the Pharmacy Follow-up of Alli Purchasers

Orlistat/Phentermine Versus Placebo/Phentermine

NCT03675191 ·Status: COMPLETED ·Phase: NA

A 35 Day Study to Investigate the Effects of GSK1521498 on Bodyweight in Obese Subjects With Over-Eating Behaviours.

NCT01195792 ·Status: COMPLETED ·Phase: PHASE2

A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

NCT07232719 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine

NCT01184560 ·Status: COMPLETED ·Phase: NA

Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers

NCT00479492 ·Status: COMPLETED ·Phase: PHASE2

A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight

NCT06824051 ·Status: COMPLETED ·Phase: PHASE1

STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY

NCT04616339 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of ATL-962 in Obese Diabetics

NCT00156897 ·Status: COMPLETED ·Phase: PHASE2

An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

NCT00109148 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

NCT06693843 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.

NCT07301437 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

NCT07035093 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease

NCT06501326 ·Status: RECRUITING ·Phase: PHASE4

A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease

NCT05931380 ·Status: COMPLETED ·Phase: PHASE3

A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943

NCT06313528 ·Status: COMPLETED ·Phase: PHASE1

A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)

NCT06584916 ·Status: COMPLETED ·Phase: PHASE3

RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity

NCT02529631 ·Status: COMPLETED ·Phase: NA

Individualized Obesity Pharmacotherapy

NCT03374956 ·Status: COMPLETED ·Phase: PHASE3

A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

NCT06859268 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects

NCT00148382 ·Status: COMPLETED ·Phase: PHASE1

Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat

NCT00991926 ·Status: COMPLETED

A Study to Investigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With Obesity

NCT06942923 ·Status: COMPLETED ·Phase: PHASE1

A Study of Xenical (Orlistat) in Overweight and Obese Adolescents

NCT00940628 ·Status: COMPLETED ·Phase: PHASE3

A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

NCT06672939 ·Status: RECRUITING ·Phase: PHASE3

A Study of LY3841136 in Healthy and Overweight Participants

NCT05295940 ·Status: COMPLETED ·Phase: PHASE1